When MNC Drug Patents Expire, Firms Turn To Making Developing-Nation Drugs (India)
This article was originally published in PharmAsia News
Executive Summary
When MNC Drug Patents Expire, Firms Turn To Making Developing-Nation Drugs (India)Expiration of drug patents apparently leads big multinational drug makers to turn to developing drugs sorely needed in developing countries. At least nine of the MNCs are attempting to develop drugs to treat tuberculosis, and seven of them also are trying for an anti-malaria drug. Others are working on drugs to treat other diseases important to developing countries, with some of them establishing research programs dedicated specifically to tropical diseases. (Click here for more